ID: ALA2441108

Max Phase: Preclinical

Molecular Formula: C20H17NO4

Molecular Weight: 335.36

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1ccc(C(=O)Nc2ccc(Oc3ccc(O)cc3)cc2)cc1

Standard InChI:  InChI=1S/C20H17NO4/c1-24-17-8-2-14(3-9-17)20(23)21-15-4-10-18(11-5-15)25-19-12-6-16(22)7-13-19/h2-13,22H,1H3,(H,21,23)

Standard InChI Key:  HSPORYRJEMPOBZ-UHFFFAOYSA-N

Associated Targets(non-human)

Androgen Receptor 399 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 335.36Molecular Weight (Monoisotopic): 335.1158AlogP: 4.45#Rotatable Bonds: 5
Polar Surface Area: 67.79Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.70CX Basic pKa: CX LogP: 4.10CX LogD: 4.10
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.72Np Likeness Score: -0.64

References

1. Yamada A, Fujii S, Mori S, Kagechika H..  (2013)  Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists.,  (10): [PMID:24900588] [10.1021/ml4001744]

Source